Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. Issue 6 (22nd November 2015)

• Record Type: Journal Article
• Authors: Hwang, William L.; Marciscano, Ariel E.; Niemierko, Andrzej; Kim, Daniel W.; Stemmer-Rachamimov, Anat O.; Curry, William T.; Barker, Fred G.; Martuza, Robert L.; Loeffler, Jay S.; Oh, Kevin S.; Shih, Helen A.; Larvie, Mykol
• Is Part Of: Neuro-oncology. Volume 18:Issue 6(2016:Jun.)
• Page Start: 863
• Page End: 872
• Publication Date: 2015-11-22
• Subjects: apparent diffusion coefficient -- histopathological grade -- meningioma -- radiotherapy -- Simpson grade; Brain Neoplasms -- Periodicals; Brain -- Tumors -- Periodicals; Brain -- Cancer -- Periodicals; Nervous system -- Cancer -- Periodicals; 616.99481
• DOI: 10.1093/neuonc/nov285
• Languages: English
• ISSNs: 1522-8517

Abstract

Abstract: Background: Risk stratification of meningiomas by histopathological grade alone does not reliably predict which patients will progress/recur after treatment. We sought to determine whether preoperative imaging and clinical characteristics could predict histopathological grade and/or improve prognostication of progression/recurrence (P/R). Methods: We retrospectively reviewed preoperative MR and CT imaging features of 144 patients divided into low-grade (2007 WHO grade I; n = 118) and high-grade (2007 WHO grades II/III; n = 26) groups that underwent surgery between 2002 and 2013 (median follow-up of 49 months). Results: Multivariate analysis demonstrated that the risk factors most strongly associated with high-grade histopathology were male sex, low apparent diffusion coefficient (ADC), absent calcification, and high peritumoral edema. Remarkably, multivariate Cox proportional hazards analysis demonstrated that, in combination with extent of resection, ADC outperformed WHO histopathological grade for predicting which patients will suffer P/R after initial treatment. Stratification of patients into 3 risk groups based on non-Simpson grade I resection and low ADC as risk factors correlated with the likelihood of P/R ( P < .001). The high-risk group (2 risk factors; n = 39) had a 45% cumulative incidence of P/R, whereas the low-risk group (0 risk factors; n = 31) had no P/R events at 5 years after treatment. Independent of histopathological grade, high-risk patients who received adjuvant radiotherapy had a lower 5-year crude rate of P/R than those without (17% vs 59%; P = .04). Conclusions: Patients with non-Simpson grade I resection and low ADC meningiomas are at significantly increased risk of P/R and may benefit from adjuvant radiotherapy and/or additional surgery.